Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)

Arturo Contis-Montes de Oca; Estefanía Rodarte-Valle; Martha Cecilia Rosales-Hernández; Edgar Abarca-Rojano; Saúl Rojas-Hernández; Manuel Jonathan Fragoso-Vázquez; Jessica Elena Mendieta-Wejebe; Ana María Correa-Basurto; Ismael Vázquez-Moctezuma; José Correa-Basurto

Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)

Arturo Contis-Montes de Oca, Estefanía Rodarte-Valle, Martha Cecilia Rosales-Hernández, Edgar Abarca-Rojano, Saúl Rojas-Hernández, Manuel Jonathan Fragoso-Vázquez, Jessica Elena Mendieta-Wejebe, Ana María Correa-Basurto, Ismael Vázquez-Moctezuma, José Correa-Basurto

Producción científica: Contribución a una revista › Comentario/Debate

Resumen

This article has been corrected: The correct author list is given below: Arturo Contis-Montes de Oca^1,*, Estefanía Rodarte-Valle^2,*, Martha Cecilia Rosales-Hernández², Edgar Abarca-Rojano³, Saúl Rojas-Hernández¹, Manuel Jonathan Fragoso-Vázquez⁴, Jessica Elena Mendieta-Wejebe², Ana María Correa-Basurto², Ismael Vázquez-Moctezuma² and José Correa-Basurto^2,5.

Idioma original	Inglés
Páginas (desde-hasta)	1225
Número de páginas	1
Publicación	Oncotarget
Volumen	10
N.º	11
Estado	Publicada - 1 feb. 2019

Otros archivos y enlaces

Enlace a la publicación en Scopus

Huella

Profundice en los temas de investigación de 'Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)'. En conjunto forman una huella única.

Citar esto

Contis-Montes de Oca, A., Rodarte-Valle, E., Rosales-Hernández, M. C., Abarca-Rojano, E., Rojas-Hernández, S., Fragoso-Vázquez, M. J., Mendieta-Wejebe, J. E., Correa-Basurto, A. M., Vázquez-Moctezuma, I., & Correa-Basurto, J. (2019). Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077). Oncotarget, 10(11), 1225.

Contis-Montes de Oca, Arturo ; Rodarte-Valle, Estefanía ; Rosales-Hernández, Martha Cecilia et al. / Correction : N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077). En: Oncotarget. 2019 ; Vol. 10, N.º 11. pp. 1225.

@article{f9893e324f8241f6adf37a54d7963024,

title = "Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)",

abstract = "This article has been corrected: The correct author list is given below: Arturo Contis-Montes de Oca1,*, Estefan{\'i}a Rodarte-Valle2,*, Martha Cecilia Rosales-Hern{\'a}ndez2, Edgar Abarca-Rojano3, Sa{\'u}l Rojas-Hern{\'a}ndez1, Manuel Jonathan Fragoso-V{\'a}zquez4, Jessica Elena Mendieta-Wejebe2, Ana Mar{\'i}a Correa-Basurto2, Ismael V{\'a}zquez-Moctezuma2 and Jos{\'e} Correa-Basurto2,5.",

author = "{Contis-Montes de Oca}, Arturo and Estefan{\'i}a Rodarte-Valle and Rosales-Hern{\'a}ndez, {Martha Cecilia} and Edgar Abarca-Rojano and Sa{\'u}l Rojas-Hern{\'a}ndez and Fragoso-V{\'a}zquez, {Manuel Jonathan} and Mendieta-Wejebe, {Jessica Elena} and Correa-Basurto, {Ana Mar{\'i}a} and Ismael V{\'a}zquez-Moctezuma and Jos{\'e} Correa-Basurto",

note = "Publisher Copyright: Contis-Montes de Oca et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",

year = "2019",

month = feb,

day = "1",

language = "Ingl{\'e}s",

volume = "10",

pages = "1225",

journal = "Oncotarget",

issn = "1949-2553",

number = "11",

}

Contis-Montes de Oca, A, Rodarte-Valle, E, Rosales-Hernández, MC , Abarca-Rojano, E , Rojas-Hernández, S , Fragoso-Vázquez, MJ , Mendieta-Wejebe, JE, Correa-Basurto, AM, Vázquez-Moctezuma, I & Correa-Basurto, J 2019, 'Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)', Oncotarget, vol. 10, n.º 11, pp. 1225.

Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077). / Contis-Montes de Oca, Arturo; Rodarte-Valle, Estefanía; Rosales-Hernández, Martha Cecilia et al.
En: Oncotarget, Vol. 10, N.º 11, 01.02.2019, p. 1225.

Producción científica: Contribución a una revista › Comentario/Debate

TY - JOUR

T1 - Correction

T2 - N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)

AU - Contis-Montes de Oca, Arturo

AU - Rodarte-Valle, Estefanía

AU - Rosales-Hernández, Martha Cecilia

AU - Abarca-Rojano, Edgar

AU - Rojas-Hernández, Saúl

AU - Fragoso-Vázquez, Manuel Jonathan

AU - Mendieta-Wejebe, Jessica Elena

AU - Correa-Basurto, Ana María

AU - Vázquez-Moctezuma, Ismael

AU - Correa-Basurto, José

N1 - Publisher Copyright: Contis-Montes de Oca et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - This article has been corrected: The correct author list is given below: Arturo Contis-Montes de Oca1,*, Estefanía Rodarte-Valle2,*, Martha Cecilia Rosales-Hernández2, Edgar Abarca-Rojano3, Saúl Rojas-Hernández1, Manuel Jonathan Fragoso-Vázquez4, Jessica Elena Mendieta-Wejebe2, Ana María Correa-Basurto2, Ismael Vázquez-Moctezuma2 and José Correa-Basurto2,5.

AB - This article has been corrected: The correct author list is given below: Arturo Contis-Montes de Oca1,*, Estefanía Rodarte-Valle2,*, Martha Cecilia Rosales-Hernández2, Edgar Abarca-Rojano3, Saúl Rojas-Hernández1, Manuel Jonathan Fragoso-Vázquez4, Jessica Elena Mendieta-Wejebe2, Ana María Correa-Basurto2, Ismael Vázquez-Moctezuma2 and José Correa-Basurto2,5.

UR - http://www.scopus.com/inward/record.url?scp=85061265270&partnerID=8YFLogxK

M3 - Comentario/Debate

SN - 1949-2553

VL - 10

SP - 1225

JO - Oncotarget

JF - Oncotarget

IS - 11

ER -

Contis-Montes de Oca A, Rodarte-Valle E, Rosales-Hernández MC , Abarca-Rojano E , Rojas-Hernández S , Fragoso-Vázquez MJ et al. Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077). Oncotarget. 2019 feb. 1;10(11):1225.